1. Home
  2. BOLT vs ATER Comparison

BOLT vs ATER Comparison

Compare BOLT & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • ATER
  • Stock Information
  • Founded
  • BOLT 2015
  • ATER 2014
  • Country
  • BOLT United States
  • ATER United States
  • Employees
  • BOLT N/A
  • ATER N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • BOLT Health Care
  • ATER Consumer Discretionary
  • Exchange
  • BOLT Nasdaq
  • ATER Nasdaq
  • Market Cap
  • BOLT 16.8M
  • ATER 15.5M
  • IPO Year
  • BOLT 2021
  • ATER N/A
  • Fundamental
  • Price
  • BOLT $5.65
  • ATER $1.36
  • Analyst Decision
  • BOLT Buy
  • ATER
  • Analyst Count
  • BOLT 3
  • ATER 0
  • Target Price
  • BOLT $50.00
  • ATER N/A
  • AVG Volume (30 Days)
  • BOLT 20.2K
  • ATER 251.1K
  • Earning Date
  • BOLT 08-12-2025
  • ATER 08-07-2025
  • Dividend Yield
  • BOLT N/A
  • ATER N/A
  • EPS Growth
  • BOLT N/A
  • ATER N/A
  • EPS
  • BOLT N/A
  • ATER N/A
  • Revenue
  • BOLT $3,638,000.00
  • ATER $94,191,000.00
  • Revenue This Year
  • BOLT N/A
  • ATER N/A
  • Revenue Next Year
  • BOLT $24.14
  • ATER $7.48
  • P/E Ratio
  • BOLT N/A
  • ATER N/A
  • Revenue Growth
  • BOLT N/A
  • ATER N/A
  • 52 Week Low
  • BOLT $5.20
  • ATER $1.22
  • 52 Week High
  • BOLT $15.60
  • ATER $3.84
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 47.50
  • ATER 39.29
  • Support Level
  • BOLT $5.68
  • ATER $1.46
  • Resistance Level
  • BOLT $6.40
  • ATER $1.56
  • Average True Range (ATR)
  • BOLT 0.27
  • ATER 0.11
  • MACD
  • BOLT 0.07
  • ATER -0.01
  • Stochastic Oscillator
  • BOLT 50.00
  • ATER 4.21

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: